Clinical trial

Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients With Prostate Cancer Before Surgery

NCT03899987

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention EC Aspirin Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention Radical Prostatectomy Find medicine records · Find other trials using this name

BIOLOGICAL · Unmapped registry intervention Recombinant Interferon Alfa-2b Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Rintatolimod Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients With Prostate Cancer Before Surgery

Design: INTERVENTIONAL · Status: ACTIVE NOT RECRUITING · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2019-11-29

PhasePHASE2

Conditions

Prostate Adenocarcinomaverified · MONDO: prostate adenocarcinoma

Stage I Prostate Cancer AJCC v8unresolved

Stage II Prostate Cancer AJCC v8unresolved

Stage IIA Prostate Cancer AJCC v8unresolved

Stage IIB Prostate Cancer AJCC v8unresolved

Stage IIC Prostate Cancer AJCC v8unresolved

Stage III Prostate Cancer AJCC v8unresolved

Stage IIIA Prostate Cancer AJCC v8unresolved

Stage IIIB Prostate Cancer AJCC v8unresolved

Stage IIIC Prostate Cancer AJCC v8unresolved

Interventions

EC AspirinDRUG

Radical ProstatectomyPROCEDURE

Recombinant Interferon Alfa-2bBIOLOGICAL

RintatolimodDRUG

Sponsors & collaborators

Roswell Park Cancer Institutelead sponsor

AIM ImmunoTech Inc.collaborator

Mapped research locations

BuffaloNew York, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03899987 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.